Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile

Antimicrob Agents Chemother. 1995 Nov;39(11):2560-3. doi: 10.1128/AAC.39.11.2560.

Abstract

An in vitro pharmacodynamic model was used to determine the killing kinetics of cefpirome against 20 Streptococcus pneumoniae strains (penicillin G MICs, > 0.125 to 2 micrograms/ml) isolated from patients with meningitis. The concentration of cefpirome was adjusted dynamically to simulate the median concentration profile obtained in the cerebrospinal fluid of adults after the infusion of a single dose of 2 g. The cefpirome MIC at which 90% of isolates are inhibited was 0.5 microgram/ml. Bactericidal activity was observed at 6 h, with mean killing of 3.51 +/- 0.34 log10 CFU/ml for all strains for which the cefpirome MIC was < 0.5 microgram/ml. In contrast, for strains for which the cefpirome MIC was > or = 0.5 microgram/ml, killing was significantly less (P < 0.05), with a mean reduction of only 2.86 +/- 0.57 log10 CFU/ml.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cefpirome
  • Ceftriaxone / pharmacology
  • Cephalosporins / cerebrospinal fluid
  • Cephalosporins / pharmacokinetics
  • Cephalosporins / pharmacology*
  • Humans
  • Meningitis, Pneumococcal / cerebrospinal fluid
  • Meningitis, Pneumococcal / microbiology*
  • Penicillin Resistance / physiology*
  • Penicillins / pharmacology
  • Streptococcus pneumoniae / drug effects*

Substances

  • Cephalosporins
  • Penicillins
  • Ceftriaxone